# Eli Lilly and Company (LLY) — Q4-2015 Earnings Results

**Report date:** 2016-01-28 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q4-2015

## Post-Earnings Brief

### Headline

Eli Lilly Beats on EPS, Stock Down 6.05%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.78 | N/A | +1.30% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in their long-term strategy but acknowledged current market challenges. They emphasized the need for continued innovation.

**Key quotes:**

> Management highlighted ongoing investments in research and development.

> They noted the importance of upcoming product launches in driving future growth.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Eli Lilly's earnings report showed a small beat on EPS, but the stock fell by over 6% in reaction. Investors may be concerned about the lack of revenue information and future guidance. The market's negative response suggests caution among investors regarding the company's near-term outlook despite the positive earnings surprise.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q4-2015_